about
Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study.Pseudoprogression as an adverse event of glioblastoma therapy.Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian CancerNK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free SurvivalA phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
P50
description
researcher
@en
wetenschapper
@nl
name
Maria Martinez Garcia
@en
Maria Martinez Garcia
@nl
type
label
Maria Martinez Garcia
@en
Maria Martinez Garcia
@nl
prefLabel
Maria Martinez Garcia
@en
Maria Martinez Garcia
@nl
P31
P496
0000-0001-5891-3935